Investment Rating - The report does not provide specific investment ratings for the industry segments mentioned [2]. Core Insights - The overall industry strategy emphasizes positive trends in terminal innovation, with a focus on smart technology, solid-state batteries, and offshore wind energy [3][4][15]. - The new energy vehicle supply chain is entering a new cycle, driven by demand expectations from key players like Tesla, Xiaomi, and CATL [4]. - Solid-state batteries are entering a critical introduction phase, with companies like Putailai benefiting from advancements in technology [4][32]. Summary by Relevant Sections New Energy Vehicle Supply Chain - Terminal innovations are expected to boost demand, with Xiaomi's YU7 and Tesla's Robotaxi leading the charge [4]. - CATL is collaborating with partners to develop L4 autonomous driving technology, investing over 3 billion [4]. Solid-State Battery Developments - The China Automotive Engineering Society has released the first group standard for solid-state batteries, clarifying definitions and standards [4]. - Innovations in current collectors are crucial for commercializing solid-state batteries, with companies like Nord and Defu Technology making strides [4][45]. Energy Storage Industry - Five major trends in energy storage are emerging, including reduced cell costs and the need for new profit models [5][40]. - The implementation of the 136 document in Xinjiang is expected to clarify future revenue prospects for energy storage projects [5][34]. Offshore Wind Energy - Leading companies in the wind energy sector are expected to report strong second-quarter results, benefiting from high demand and improved product structures [9]. - Shanghai's marine industry development plan aims to accelerate the research and application of large-scale floating wind turbines [44]. AI and New Energy Integration - Companies like Tesla and CATL are advancing in the integration of AI with new energy technologies, with significant investments in humanoid robots and autonomous driving [6][41]. - The humanoid robot market is projected to drive advancements in battery technology, particularly solid-state batteries [37]. Market Trends and Pricing - Recent price adjustments in lithium carbonate and other battery materials indicate market volatility, with lithium carbonate prices showing a 20.42% decrease year-to-date [14][19]. - The report highlights the importance of monitoring material prices as they directly impact the profitability of the new energy vehicle and battery sectors [11][13].

Investment Rating - The report maintains a positive outlook on the basic chemical industry [1] Core Insights - The prices of bio-jet fuel (SAF) and bio-diesel have increased, with SAF reaching $2230 per ton, up 9.85% week-on-week and 20.28% year-to-date [3][11] - Refrigerant prices remain strong, with R32 and R134a showing slight increases of 0.96% and 1.03% respectively [4][11] - The demand for high-performance fibers and lightweight materials is expected to rise due to advancements in robotics and the low-altitude economy [5][28] Summary by Sections 1. Sub-industry Tracking - Bio-jet fuel (SAF) and bio-diesel prices are on the rise, with SAF priced at $2230 per ton and bio-diesel at 8100 RMB per ton [3][11] - Refrigerant prices are stable, with R32 at 52500 RMB per ton and R134a at 49000 RMB per ton [4][11] - Prices for vitamins, multi-crystalline silicon, and other materials have declined [4][11] 2. Electronic Chemicals - The electronic chemicals sector focuses on materials for the electronics industry, including wet electronic chemicals and photolithography materials [13][16] - The market for semiconductor materials is projected to grow, with a significant increase in domestic production capabilities [20][23] 3. New Quality Productivity - Carbon fiber and ultra-high molecular weight polyethylene (UHMWPE) are highlighted as key materials benefiting from the low-altitude economy and robotics [28][30] - PEEK materials are gaining traction in humanoid robotics, with demand expected to grow significantly [33] 4. Lithium Battery/Storage Materials - Conductive agents like carbon black and carbon nanotubes are essential for lithium battery materials, with current market prices showing a downward trend [36][39] - Sodium-ion battery materials are also gaining attention due to their cost advantages [39] 5. Renewable and Modified Plastics - The demand for recycled plastics is increasing, with a notable rise in the proportion of recycled materials used in packaging [55][58] - Specialty engineering plastics are in demand across various industries, including automotive and aerospace [55][60] 6. Coatings, Inks, and Pigments - The demand for new functional coating materials is growing, driven by the automotive and consumer electronics sectors [62][64] 7. Market Performance - The basic chemical index has shown a 4.15% increase, outperforming the overall market [66][67]

Group 1: Core Insights - The report highlights five key stocks for July, each representing different industries with strong growth potential and attractive valuations [1][3][4]. Group 2: Industry Summaries - **Electronics - Huakin Technology (603296.SH)**: The company is a global leader in smart product platforms, with data center business expected to ramp up in the second half of the year [3]. - **Textiles and Apparel - Zhejiang Natural (605080.SH)**: The stock is undervalued due to tariff impacts, but is seeing a recovery in orders for old products alongside new product launches, indicating high growth potential [4]. - **Social Services - Tianli International Holdings (1773.HK)**: This company is a leader in K12 private education in China, focusing on high school education and diversifying its brand influence [4]. - **Oil and Petrochemicals - CNOOC Engineering (600583.SH)**: The company benefits from overseas orders, with rapid growth in annual and quarterly performance; projected dividend yield for 2024 is close to 4% [4]. - **New Energy - Putailai (603659.SH)**: The company is expected to see a gradual recovery in lithium battery anode performance, with small-scale production orders for CVD silicon-carbon anodes and plans for production in 2025 [4].

Investment Rating - The report maintains a "Buy" rating for multiple companies in the pharmaceutical sector, including Junshi Bioscience, Hualing Pharmaceutical-B, and others [2]. Core Insights - The report emphasizes the broad market for lipid-lowering treatments, particularly focusing on the competitive landscape of PCSK9-targeted drugs, with approximately 500 million adults in China suffering from dyslipidemia, including 120 million with high cholesterol [3][15]. - The pharmaceutical sector saw a 1.60% increase this week, underperforming the CSI 300 index by 0.35 percentage points, with sub-sectors like medical infrastructure and life sciences performing better than generics and innovative drugs [4][31]. Summary by Sections 1. Industry Perspective and Investment Recommendations - The lipid-lowering market is vast, with intense competition in PCSK9-targeted drugs [15]. - Investment strategies should focus on innovative drugs, particularly in the context of increased liquidity and risk appetite in the market [4][31]. 2. Pharmaceutical Sector Performance - The pharmaceutical sector's performance was mixed, with medical infrastructure and life sciences leading, while generics and innovative drugs lagged [4][37]. - The overall P/E ratio for the pharmaceutical industry is 27.69, with a premium of 35.26% compared to the broader A-share market [37]. 3. Company Dynamics - Notable company announcements include Baiyoutai's licensing agreement for BAT2406 in Latin America and Yifan Pharmaceutical's approval for clinical trials of a growth hormone injection [38][40]. - Companies like WuXi AppTec and Lijun Group have made significant moves, including share buybacks and new product approvals [39][41]. 4. Industry Trends - The report highlights the upcoming patent expirations for major small molecule drugs, which could lead to increased demand for raw materials [5][32]. - The report also notes the expected recovery in overseas demand, which may improve the performance of CXO companies [34]. 5. Research and Development Focus - The report discusses the clinical progress of various PCSK9-targeted therapies, including monoclonal antibodies and gene editing approaches, indicating a strong pipeline in this area [3][23][25]. - The competitive landscape for PCSK9 drugs in China is characterized by pricing and adherence challenges, with several products already on the market [27].

Investment Rating - The report does not provide specific ratings for sub-industries such as white goods, black goods, small appliances, and kitchen appliances [3] Core Insights - The white goods production is expected to face short-term pressure in Q3 2025, with production volumes for air conditioners, refrigerators, and washing machines projected to decline by 1.9%, 2.4%, and 4.2% respectively in July 2025 [4] - The report anticipates a recovery in the white goods sector due to the implementation of domestic replacement policies and inventory buildup in overseas channels, which may help improve the sector's performance [4] - Xiaomi has launched AI glasses with a starting price of 1999 yuan, indicating innovation in the consumer electronics space [5] Market Performance - The home appliance sector saw a 2.02% increase in the week of June 23-27, 2025, while the year-to-date performance shows a decline of 1.44%, ranking 18th among the Shenwan primary industries [11][12] - Notable stock performances include Springlight Technology, He Sheng New Materials, and Rongtai Health, with Springlight Technology achieving a year-to-date increase of 96.50% [11] Real Estate and Raw Material Data - In May 2025, the transaction area and number of transactions for commercial housing in 30 major cities in China were 8.21 million square meters (-4.95%) and 83,700 units (-2.16%) respectively, indicating a slight recovery in demand [17][20] - Raw material prices show mixed trends, with LME copper and aluminum prices increasing by 6.67% and 5.06% year-on-year, while steel and plastic prices have decreased [21][24] Investment Recommendations - The report suggests that the white goods sector is likely to benefit from ongoing replacement policies and a recovery in real estate transactions, making it a favorable investment opportunity [29] - Key companies recommended for investment include Midea Group, Haier Smart Home, Gree Electric Appliances, and Hisense Home Appliances, all of which have strong production capabilities to mitigate the impact of U.S. tariff policies [29][30]

Investment Rating - The industry rating is optimistic, expecting overall returns to exceed the CSI 300 Index by more than 5% in the next six months [11]. Core Insights - The report highlights the implementation of six optimized housing provident fund policies in Shenyang starting July 1, 2025, which includes extending the minimum down payment ratio for housing loans to 15% until December 31, 2025, and increasing loan limits for high-quality new residential properties [6]. - The report notes a decline in the equity market on June 26, 2025, with the Shanghai Composite Index and Shenzhen Composite Index falling by 0.22% and 0.34%, respectively, while the Shenwan Real Estate Index decreased by 0.43% [4]. - The report identifies significant individual stock performances within the real estate sector, with notable gains from companies such as Nandu Property and Bright Real Estate, while companies like China International Trade and Jintou City Development experienced substantial declines [5]. Summary by Sections Market Conditions - As of June 26, 2025, the overall equity market is experiencing a downturn, with major indices showing declines, particularly in the real estate sector [4]. Policy Developments - Shenyang's housing provident fund management committee approved six policy measures aimed at optimizing housing loans, including extending the minimum down payment period and increasing loan limits for certain demographics [6]. Company Performance - The report lists the top five gainers in the real estate sector, with Nandu Property leading at a 5.16% increase, while the largest decliners include China International Trade with an 8.37% drop [5].

Investment Rating - The industry rating is neutral, indicating that the overall return is expected to be between -5% and 5% relative to the CSI 300 index over the next six months [9]. Core Insights - The pharmaceutical sector experienced a slight increase of +0.41% on June 25, 2025, underperforming the CSI 300 index by 1.03 percentage points, ranking 23rd among 31 sub-industries in the Shenwan classification [4]. - Among sub-industries, medical consumables (+1.34%), medical devices (+1.24%), and hospitals (+1.23%) performed well, while offline pharmacies (-0.10%), blood products (+0.10%), and in vitro diagnostics (+0.12%) lagged behind [4]. - AstraZeneca's two new drugs, AZD6234 and AZD9550, received clinical trial approval in China for long-term weight management in overweight or obese adults with at least one obesity-related comorbidity [5]. Summary by Sections Market Performance - On June 25, 2025, the pharmaceutical sector's performance was +0.41%, underperforming the CSI 300 index by 1.03 percentage points [4]. - The top three gainers were Huachang Technology (+13.48%), Shuyuan Pingmin (+6.80%), and Huitai Medical (+6.07%), while the top three losers were Yiming Pharmaceutical (-8.56%), Yong'an Pharmaceutical (-7.87%), and Beilu Pharmaceutical (-7.35%) [4]. Industry News - AstraZeneca's AZD6234 is a long-acting insulin receptor agonist approved for clinical trials in China, while AZD9550 is a synthetic GLP-1/glucagon dual receptor agonist, marking its first clinical approval in China [5]. - Yifan Pharmaceutical announced the approval for clinical trials of its biosimilar insulin injection [6]. - Shenzhou Cell and Hanyu Pharmaceutical also received approvals for their respective clinical trials and drug listings [6].

Group 1: Market Overview - The stock market has seen a significant upward trend, with the Shanghai Composite Index breaking through resistance levels and reaching a year-to-date high, supported by increased trading volume of 1.6 trillion yuan, up by 188.2 billion yuan from the previous trading day [4][20]. - The bond market is expected to experience high-level fluctuations, influenced by the performance of the stock market, which may continue to suppress bond market performance if it remains strong [4][16]. - The US stock market is anticipated to challenge new highs as speculative sentiment returns, with reduced risks from rising oil prices and US Treasury yields [5][27]. Group 2: Sector Performance - In the A-share market, sectors such as military, securities, internet finance, and insurance have shown strong performance, while oil and gas, pesticides, and film sectors have lagged [20][21]. - The commodity market has seen a decline in the Wenhua Commodity Index by 0.5%, with energy sectors leading the downturn, while non-ferrous and ferrous metals recorded gains [6][35]. Group 3: Policy and Economic Developments - Domestic policies emphasize expanding domestic demand and boosting consumption to promote high-quality economic development, as highlighted by the Vice Premier's recent remarks [7][41]. - Internationally, the EU is preparing to implement additional tariff countermeasures against the US, indicating ongoing trade tensions [7][42].

Investment Rating - The industry rating is optimistic, expecting overall returns to exceed the CSI 300 index by more than 5% in the next six months [10]. Core Insights - The report highlights a significant land auction in Beijing, where a plot was sold for 2.08 billion yuan, indicating active market participation [5]. - The report notes that the real estate sector is experiencing a general upward trend, with the Shanghai Composite Index and Shenzhen Composite Index rising by 1.15% and 1.79% respectively on June 24, 2025 [3]. - The report mentions that the issuance of housing vouchers in Huizhou has accelerated, with 513 vouchers issued covering 230 projects, reflecting a rapid implementation of real estate policies [5]. Market Performance - The report lists the top five performing stocks in the real estate sector, with gains of 4.28%, 4.17%, 4.00%, 3.77%, and 3.66% for Zhongtian Service, Jintou City Development, Phoenix Holdings, Chunlan Holdings, and Zhongzhou Holdings respectively [4]. - Conversely, the report notes declines in stocks such as Wantong Development and Shibei Gaoxin, with losses of -5.48% and -0.21% respectively [4]. Company Announcements - China Railway Real Estate Group announced a reduction in the coupon rate of its bond from 3.4% to 2.36% [8]. - Vanke reported a loan application of 1.7 billion yuan, with a current balance of 1.217 billion yuan, and an extension of the loan term by two years [8].

投资策略 策略日报（2025.06.24）：突破 策 略 研 究 太 平 2025 年 06 月 24 日 相关研究报告 洋 证 券 股 份 有 限 公 司 证 券 动>>--2025-06-23 跌>>--2025-06-20 << 策 略 日 报 （ 2025.06.19 ） 调 整>>--2025-06-19 期：金融、周期领涨>>--2025-06-16 期：资金转流出>>--2025-06-16 E-MAIL：zhangdd@tpyzq.com 分析师登记编号：S1190522040001 E-MAIL：xuzm@tpyzq.com 分析师登记编号：S1190525050001 大类资产跟踪 <<策略日报（2025.06.23）反者道之 <<策略日报（2025.06.20）缩量下 债券市场：利率债低开低走，股债跷跷板效应明显。今日上证指数 放量突破颈线压制，且呈均线排列结构，虽然基本面的疲弱仍将支撑债市， 但股市若继续走强仍将压制债市表现，预计债市后续将高位震荡运行。后 续展望：股市大盘突破，债市预计高位震荡。 研 究 报 告 <<估值与盈利周观察——6 月第 2 <<流动性与仓位周观察——6 月第 ...